Federal contractor · MARIETTA, GA

INLIGHTA BIOSCIENCES L.L.C.

No contract obligations recorded for INLIGHTA BIOSCIENCES L.L.C. in FY2026. Since FY2018: $298.2K. It also received $1M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
KCSBM7ASMA34
Small businessWoman-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 298.2KFY2018
  2. 0FY2019
  3. 0FY2023

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for INLIGHTA BIOSCIENCES L.L.C. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

INLIGHTA BIOSCIENCES L.L.C. received $1M in federal assistance in FY2026, on 3 actions (0 new awards), 0% vs FY2025. Its largest program was 93.837 · Cardiovascular Diseases Research ($1M).

Assistance · FY2026
$1M
New awards
0
Actions
3
Since FY2021
$5M

Assistance by fiscal year

  1. 984.3KFY2021
  2. 954.2KFY2022
  3. 1.3MFY2023
  4. -316KFY2024
  5. 1MFY2025
  6. 1MFY2026

By type

  1. Grants$1M100%

Top programs

  1. 93.837 · Cardiovascular Diseases Research$1M100%

Awarding agencies

  1. National Institutes of Health$1M100%
    Department of Health and Human Services

Largest awards

  1. PRECISION MRI WITH PROTEIN CONTRAST AGENT FOR NONINVASIVE DETECTION OF LUNG FIBROSIS - SUMMARY LUNG DISEASES, SUCH AS INTERSTITIAL LUNG…$2.1M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Aug 25, 2025 – Sep 11, 2026· R42HL170898
  2. NON-INVASIVE STAGING OF METASTASIS BY PRECISION MRI - PROJECT SUMMARY/ABSTRACT THIS SBIR APPLICATION WILL DEVELOP AN IMPROVED CONTRAST…$2M
    93.394 · Cancer Detection and Diagnosis Research· National Institutes of Health· Project grant· Sep 22, 2022 – Jan 8, 2026· R44CA268403
  3. PRECISION MRI WITH A NOVEL PROTEIN CONTRAST AGENT FOR EARLY DETECTION AND STAGING OF LUNG FIBROSIS - SUMMARY LUNG DISEASES, SUCH AS…$298.8K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 15, 2023 – Aug 24, 2026· R41HL170898

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.